Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin-tetracycline-based quadruple regimen vs clarithromycin-based regimen for Helicobacter pylori eradication
IRCT20200707048038N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin, tetracycline and clarithromycin in Helicobacter pylori infection (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Aug 2020; status: completed.
02
Drugs
levofloxacintetracyclineclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20200707048038N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200707048038N1.